AUXILIUM PHARMACEUTICALS INC's ticker is AUXL and the CUSIP is 05334D107. A total of 1 filers reported holding AUXILIUM PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $4,016,000 | -30.3% | 116,807 | -39.5% | 0.01% | -33.3% |
| Q3 2014 | $5,761,000 | -6.5% | 192,991 | -37.2% | 0.01% | -14.3% |
| Q2 2014 | $6,162,000 | -21.1% | 307,170 | +6.9% | 0.01% | +7.7% |
| Q1 2014 | $7,813,000 | +172.5% | 287,440 | +107.9% | 0.01% | +160.0% |
| Q4 2013 | $2,867,000 | +59.7% | 138,230 | +40.3% | 0.01% | +25.0% |
| Q3 2013 | $1,795,000 | +5.6% | 98,506 | -3.6% | 0.00% | 0.0% |
| Q2 2013 | $1,700,000 | – | 102,221 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,883,879 | $101,243,000 | 9.44% |
| Tamarack Capital Management, LLC | 1,250,000 | $25,913,000 | 6.14% |
| Healthcare Value Capital, LLC | 334,481 | $6,934,000 | 5.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,113,385 | $85,270,000 | 4.42% |
| KING INVESTMENT ADVISORS INC/TX | 312,890 | $6,486,000 | 2.96% |
| Broadfin Capital, LLC | 961,100 | $19,924,000 | 2.63% |
| SECTOR GAMMA AS | 462,504 | $9,588,000 | 2.59% |
| TAMRO Capital Partners LLC | 1,898,717 | $39,360,000 | 1.62% |
| Elk Creek Partners, LLC | 84,090 | $1,743,000 | 1.25% |
| Artal Group S.A. | 1,500,000 | $31,095,000 | 1.12% |